PHILIPS HEADQUARTERS CAMBRIDGE vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 4 for PHILIPS HEADQUARTERS CAMBRIDGE.

PHILIPS HEADQUARTERS CAMBRIDGE: 0 warning letters, 4 recalls, 0 approval records, 0 Form 483s.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Side by side

PHILIPS HEADQUARTERS CAMBRIDGE — Warning letters0

Philips North America — Warning letters0

PHILIPS HEADQUARTERS CAMBRIDGE — Recalls4

Philips North America — Recalls355

PHILIPS HEADQUARTERS CAMBRIDGE — Approval records0

Philips North America — Approval records0

PHILIPS HEADQUARTERS CAMBRIDGE — Form 483s0

Philips North America — Form 483s0

Timeline

PHILIPS HEADQUARTERS CAMBRIDGE

Most recent FDA action: May 31, 2023

Full history →

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"PHILIPS HEADQUARTERS CAMBRIDGE vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/philips-headquarters-cambridge-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗